The disruption of GITR–GITR-L interactions enhanced NK cell activation in pre-clinical acute myeloid leukemia and chronic lymphocytic leukemia models [40,41]. The gene discussed is TNFRSF18; the disease is B-cell chronic lymphocytic leukemia.